Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
39.52
-0.48 (-1.20%)
May 21, 2026, 3:00 PM CST

SHA:688363 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,9474,1955,3616,0756,3594,947
Other Revenue
3.763.769.490.60.410.55
3,9514,1995,3716,0766,3594,948
Revenue Growth (YoY)
-22.36%-21.82%-11.61%-4.45%28.53%87.93%
Cost of Revenue
1,3191,3521,4821,6591,4821,118
Gross Profit
2,6322,8473,8894,4174,8773,829
Selling, General & Admin
1,9072,0553,1183,3313,4392,736
Research & Development
452.96472.14466.25446.35388.19284.34
Other Operating Expenses
47.3742.7746.4862.0173.2556.95
Operating Expenses
2,4492,6123,6563,8473,9153,083
Operating Income
182.59235.23232.36570.18961.48746.46
Interest Expense
-6.42-6.42-9.17-10.74-14.52-11.08
Interest & Investment Income
7.637.6314.1139.7850.4445.07
Currency Exchange Gain (Loss)
5.235.232.973.925.19-12.05
Other Non Operating Income (Expenses)
-7.232.58-4.761.71-3.88-2.62
EBT Excluding Unusual Items
181.81244.26235.51604.841,019765.77
Impairment of Goodwill
-3.06-3.06-74.09---
Gain (Loss) on Sale of Investments
12.2714.15-11.48-18.74-0.147.39
Gain (Loss) on Sale of Assets
0.440.42-0.11-3.42-0.240.04
Asset Writedown
-3.39-2.36-0.86-1.87-0.53-3.91
Other Unusual Items
80.480.464.43120.91118.32120.9
Pretax Income
268.47333.8213.39701.721,136890.2
Income Tax Expense
13.4542.6544.99118.98174.73114.64
Earnings From Continuing Operations
255.02291.15168.41582.74961.38775.56
Minority Interest in Earnings
-0.20.915.869.819.546.78
Net Income
254.82292.06174.27592.56970.92782.33
Net Income to Common
254.82292.06174.27592.56970.92782.33
Net Income Growth
677.05%67.59%-70.59%-38.97%24.10%21.14%
Shares Outstanding (Basic)
473479484482481480
Shares Outstanding (Diluted)
473479484482483483
Shares Change (YoY)
-2.70%-1.09%0.48%-0.27%0.03%0.95%
EPS (Basic)
0.540.610.361.232.021.63
EPS (Diluted)
0.540.610.361.232.011.62
EPS Growth
698.64%69.44%-70.73%-38.81%24.07%20.00%
Free Cash Flow
449.95301.77-156.88-330.68-61.22491.85
Free Cash Flow Per Share
0.950.63-0.32-0.69-0.131.02
Dividend Per Share
0.1900.1900.1100.3800.6100.490
Dividend Growth
72.73%72.73%-71.05%-37.70%24.49%19.51%
Gross Margin
66.62%67.80%72.41%72.69%76.69%77.40%
Operating Margin
4.62%5.60%4.33%9.38%15.12%15.09%
Profit Margin
6.45%6.96%3.25%9.75%15.27%15.81%
Free Cash Flow Margin
11.39%7.19%-2.92%-5.44%-0.96%9.94%
EBITDA
500.86537.69471.59775.491,124866.92
EBITDA Margin
12.68%12.80%8.78%12.76%17.68%17.52%
D&A For EBITDA
318.26302.46239.23205.31162.69120.46
EBIT
182.59235.23232.36570.18961.48746.46
EBIT Margin
4.62%5.60%4.33%9.38%15.12%15.09%
Effective Tax Rate
5.01%12.78%21.08%16.96%15.38%12.88%
Revenue as Reported
4,1994,1995,3716,0766,3594,948
Advertising Expenses
-649.371,3771,7902,0511,583
Source: S&P Global Market Intelligence. Standard template. Financial Sources.